We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-5.98%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.92B
AUM Growth
-$382M
Cap. Flow
-$115M
Cap. Flow %
-5.98%
Top 10 Hldgs %
45.28%
Holding
275
New
41
Increased
31
Reduced
101
Closed
38

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$24.8M
2
ASTH icon
Astrana Health
ASTH
+$16.6M
3
KSPI icon
Kaspi.kz JSC
KSPI
+$15.8M
4
LLY icon
Eli Lilly
LLY
+$15.2M
5
GPC icon
Genuine Parts
GPC
+$13M

Top Sells

Rank Stock Value
1
UWMC icon
UWM Holdings
UWMC
+$30.9M
2
WDC icon
Western Digital
WDC
+$24.7M
3
HRMY icon
Harmony Biosciences
HRMY
+$13.6M
4
SUNC
SunocoCorp LLC
SUNC
+$11.6M
5
GXO icon
GXO Logistics
GXO
+$10.6M

Sector Composition

Rank Sector Weight
1 Healthcare 23.91%
2 Consumer Discretionary 7.8%
3 Financials 6.79%
4 Industrials 3.72%
5 Materials 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSLE
126
Satellos Bioscience
MSLE
$204M
$1.3M 0.07%
+230,833
New +$2.27M
HYLN icon
127
Hyliion Holdings
HYLN
$663M
$1.28M 0.07%
725,000
-100,000
-12% -$201K
WLIIU
128
Willow Lane Acquisition Corp II Unit
WLIIU
$1.26M 0.07%
+125,000
New +$1.26M
PMN icon
129
ProMIS Neurosciences
PMN
$109M
$1.18M 0.06%
+92,850
New +$1.38M
IRS
130
IRSA Inversiones y Representaciones
IRS
$1.26B
$1.13M 0.06%
70,000
-85,000
-55% -$1.35M
INAB icon
131
IN8bio
INAB
$11.5M
$1.07M 0.06%
724,637
– –
LWAC
132
LightWave Acquisition Corp
LWAC
$1.02M 0.05%
100,000
– –
AMPY icon
133
Amplify Energy
AMPY
$163M
$998K 0.05%
160,000
-28,679
-15% -$156K
AXTI icon
134
AXT Inc
AXTI
$3.09B
$969K 0.05%
17,000
-58,000
-77% -$1.92M
DIBS icon
135
1stdibs.com
DIBS
$145M
$967K 0.05%
175,786
– –
SRZN icon
136
Surrozen
SRZN
$229M
$961K 0.05%
33,000
-8,999
-21% -$216K
INFU icon
137
InfuSystem Holdings
INFU
$184M
$927K 0.05%
100,465
– –
ANRO icon
138
Alto Neuroscience
ANRO
$1.04B
$899K 0.05%
40,000
-24,782
-38% -$459K
PPIH
139
Perma-Pipe International
PPIH
$204M
$894K 0.05%
30,000
-6,954
-19% -$214K
RSVR icon
140
Reservoir Media
RSVR
$700M
$881K 0.05%
90,000
-66,954
-43% -$555K
AVTX icon
141
Avalo Therapeutics
AVTX
$976M
$849K 0.04%
56,850
– –
XHR
142
Xenia Hotels & Resorts
XHR
$1.98B
$816K 0.04%
55,000
-398,000
-88% -$6M
CRBP icon
143
Corbus Pharmaceuticals
CRBP
$170M
$803K 0.04%
85,543
– –
SRRK icon
144
PUT
Scholar Rock
SRRK
$5.71B
$796K 0.04%
16,200
– –
IMRX icon
145
Immuneering
IMRX
$279M
$794K 0.04%
150,697
– –
CCCC icon
146
C4 Therapeutics
CCCC
$376M
$789K 0.04%
300,000
-100,000
-25% -$235K
OBIO icon
147
Orchestra BioMed
OBIO
$224M
$786K 0.04%
185,000
-19,076
-9% -$81.2K
ASMB icon
148
Assembly Biosciences
ASMB
$506M
$773K 0.04%
27,863
– –
PRE icon
149
Prenetics Global
PRE
$319M
$773K 0.04%
40,000
-35,000
-47% -$652K
OYSE
150
Oyster Enterprises II Acquisition Corp
OYSE
$763K 0.04%
75,000
– –
4 5
6
7 8

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, 683 Capital Management held 275 positions worth $1.92B, down 17% from $2.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

683 Capital Management withdrew a net $115M in Q1 2026, closing 38 positions and reducing 101 holdings. Its most notable exit was UWM Holdings, an estimated $30.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in Astrana Health worth $17.2M.

  • 683 Capital Management's largest Q1 2026 buy was Astrana Health: 700,000 shares worth $17.2M.
  • 683 Capital Management added most to Becton Dickinson in Q1 2026, an estimated $24.8M increase.
  • 683 Capital Management's biggest Q1 2026 reduction was GXO Logistics, cutting an estimated $10.6M.
  • 683 Capital Management fully exited UWM Holdings in Q1 2026, selling an estimated $30.9M.
  • 683 Capital Management's ten largest holdings make up 45% of its $1.92B portfolio in Q1 2026.
  • 683 Capital Management opened 41 new positions and closed 38 in Q1 2026.
  • 683 Capital Management's portfolio value fell 17% quarter-over-quarter to $1.92B.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.